Data gathered: January 2
AI Stock Analysis - Absci (ABSI)
Analysis generated March 15, 2024. Powered by Chat GPT.
Absci is a biotechnology company that specializes in using artificial intelligence and synthetic biology to discover and develop next-generation biologic drugs. Absci's platform aims at drug discovery, biomanufacturing optimization, and novel protein creation, seeking to revolutionize the pharmaceutical industry. Their promise lies in reducing the time and cost of drug development, potentially offering a competitive edge in bringing new therapies to market.
Stock Alerts - Absci (ABSI)
 |
Absci | January 2 Price is up by 5.7% in the last 24h. |
|
Absci | December 30 Price is down by -5.1% in the last 24h. |
|
Absci | December 27 Price is down by -5% in the last 24h. |
|
Absci | December 20 Price is up by 5.1% in the last 24h. |
Alternative Data for Absci
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 4 | Sign up | Sign up | Sign up |
| Sentiment | 97 | Sign up | Sign up | Sign up |
| Webpage traffic | 6,000 | Sign up | Sign up | Sign up |
| Employee Rating | 60 | Sign up | Sign up | Sign up |
| Google Trends | 8 | Sign up | Sign up | Sign up |
| Patents | 19 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | N/A | Sign up | Sign up | Sign up |
| Facebook Followers | 200 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 2 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 1,510 | Sign up | Sign up | Sign up |
| Twitter Followers | 2,392 | Sign up | Sign up | Sign up |
| Twitter Mentions | 18 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 408 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 35 | Sign up | Sign up | Sign up |
| Linkedin Employees | 184 | Sign up | Sign up | Sign up |
About Absci
Absci is a generative AI drug creation company that combines AI with scalable wet lab technologies to create better biologics for patients, faster.
| Price | $2.71 |
| Target Price | Sign up |
| Volume | 2,100,000 |
| Market Cap | $301M |
| Year Range | $2.55 - $5.21 |
| Dividend Yield | 0% |
| Analyst Rating | 86% buy |
| Industry | Biotechnology |
In the news
 |
Absci Co. (NASDAQ:ABSI) Short Interest UpdateDecember 30 - ETF Daily News |
 |
Why Absci Corporation (ABSI) Is One of the Best Biotech Penny Stocks to Invest in Now?December 30 - Yahoo |
|
Absci Co. (NASDAQ:ABSI) Shares Purchased by Wellington Management Group LLPDecember 20 - ETF Daily News |
|
60,410 Shares in Absci Co. (NASDAQ:ABSI) Purchased by Verition Fund Management LLCDecember 16 - ETF Daily News |
|
Absci Co. (NASDAQ:ABSI) Receives Average Rating of “Buy” from AnalystsDecember 15 - ETF Daily News |
 |
Absci’s (ABSI) Buy Rating Reiterated at HC WainwrightDecember 15 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 1.7M | 10M | -8.7M | -27M | 0 | 0.000 |
| Q2 '24 | 1.3M | 9.3M | -8.1M | -25M | -23M | -0.220 |
| Q1 '24 | 900,000 | 8.7M | -7.8M | -22M | -20M | -0.220 |
| Q4 '23 | 340,000 | 10M | -9.9M | -24M | -22M | -0.250 |
| Q3 '23 | 740,000 | 10M | -9.6M | -22M | -21M | -0.240 |
Insider Transactions View All
| Jonasson Zachariah filed to sell 384,751 shares at $5. June 14 '24 |
| Phoenix Venture Partners II LP filed to sell 11,279,522 shares at $4.4. May 28 '24 |
| Redmile Group, LLC filed to buy 8,253,316 shares at $4.5. March 5 '24 |
| Phoenix Venture Partners II LP filed to sell 14,379,522 shares at $1.4. February 14 '24 |
| Phoenix Venture Partners II LP filed to sell 14,379,522 shares at $1.4. February 14 '24 |
Similar companies
Read more about Absci (ABSI) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Absci?
The Market Cap of Absci is $301M.
What is the current stock price of Absci?
Currently, the price of one share of Absci stock is $2.71.
How can I analyze the ABSI stock price chart for investment decisions?
The ABSI stock price chart above provides a comprehensive visual representation of Absci's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Absci shares. Our platform offers an up-to-date ABSI stock price chart, along with technical data analysis and alternative data insights.
Does ABSI offer dividends to its shareholders?
As of our latest update, Absci (ABSI) does not offer dividends to its shareholders. Investors interested in Absci should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Absci?
Some of the similar stocks of Absci are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.